New variant of MHC class II deficiency with interleukin-2 abnormality.
Cunningham-Rundles
S
S
Division of Pediatric Hematology/Oncology, Rogosin Institute, Cornell University Medical Center, New York, New York.
Yeger-Arbitman
R
R
Nachman
S A
SA
Kaul
S
S
Fotino
M
M
D005260:Female; D015483:HIV Antibodies / Q000032:analysis; D006681:HLA-D Antigens / Q000172:deficiency*; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000235:genetics / Q000276:immunology; D007223:Infant; D007376:Interleukin-2 / Q000378:metabolism*; D007700:Kinetics; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D010835:Phytohemagglutinins / Q000494:pharmacology; D011020:Pneumonia, Pneumocystis / Q000276:immunology; D015375:Receptors, Interleukin-2 / Q000097:blood
D015483:HIV Antibodies; D006681:HLA-D Antigens; D007376:Interleukin-2; D010835:Phytohemagglutinins; D015375:Receptors, Interleukin-2